EP3833662
INHIBITORS OF KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.8.2019EP published:
17.1.2024EP application number:
19773579.8
EPO information:
European Patent Register
Max expiry date:
18.8.2039
Title in English:
INHIBITORS OF KEAP1-NRF2 PROTEIN-PROTEIN INTERACTIONLanguage of the patent:
English
Timeline
Today
19.8.2019EP application
17.1.2024EP Publication
Owner
Name:
Janssen Pharmaceutica NVAddress:
Turnhoutseweg 30, 2340 Beerse, BE
Inventor
Name:
CHAI, WenyingAddress:
San Diego, California 92121, US
Name:
HIRST, Gavin C.Address:
San Diego, California 92130, US
Name:
KREUTTER, Kevin D.Address:
Arlington, Massachusetts 02476, US
Name:
KUMMER, David A.Address:
San Diego, California 92121, US
Name:
MCCLURE, Kelly J.Address:
San Diego, California 92121, US
Name:
NISHIMURA, Rachel T.Address:
San Diego, California 92121, US
Name:
SHIH, Amy Y.Address:
San Diego, California 92121, US
Name:
VENABLE, Jennifer D.Address:
San Diego, California 92121, US
Name:
VENKATESAN, HariharanAddress:
San Diego, California 92121, US
Name:
WEI, JianmeiAddress:
San Diego, California 92121, US
Name:
BARBAY, J. KentAddress:
Spring House, Pennsylvania 19477, US
Priority
Number:
201862719978 PDate:
20.8.2018Country:
US
Number:
201962801433 PDate:
5.2.2019Country:
US
Number:
201962823450 PDate:
25.3.2019Country:
US
Number:
201962875737 PDate:
18.7.2019Country:
US
Number:
201962881639 PDate:
1.8.2019Country:
US
Classification
Categories:
C07D 417/10, C07D 417/14, C07D 419/10, C07D 419/14, C07D 471/04, C07D 487/04, C07D 513/04, C07D 513/14, C07D 515/04, C07D 515/14, A61K 31/554, A61P 3/00, A61P 11/00, A61P 9/00, A61P 29/00